Latest Research On Chronic T-cell Lymphocytic Leukemia

Doctors are learning more about T-cell Leukemia, ways to prevent it, the best way to treat it. They are also looking at how to give the best care to people diagnosed with this disease. The following research areas may comprise new alternatives for patients with the help of clinical trials. Always talk with the doctor about the best diagnostic and treatment options for you.

  • New treatment combinations – New treatments are taking place in clinical trials, including new immunotherapy and chemotherapy combinations. For ATLL, several new treatments are being studied, including arsenic trioxide (Trisenox), bortezomib (Velcade), and daclizumab (Zenapax), which is an anti-IL2 antibody. There is research taking place with Romidepsin for patients with mycosis fungoides.

Palliative care – Clinical trials are going on to find more acceptable ways of lessening symptoms and side effects of current cancer treatments to improve comfort and quality of life during treatment.